AMERICAN CENTURY COMPANIES INC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,859,849
-36.7%
408,758
-2.0%
0.00%
-50.0%
Q2 2023$2,936,842
+50.5%
417,165
+30.6%
0.00%0.0%
Q1 2023$1,950,984
-3.9%
319,310
+0.5%
0.00%0.0%
Q4 2022$2,029,854
-55.0%
317,661
-32.5%
0.00%
-50.0%
Q3 2022$4,508,000
-12.2%
470,588
+1.2%
0.00%0.0%
Q2 2022$5,134,000
-24.6%
465,084
+13.7%
0.00%
-20.0%
Q1 2022$6,808,000
-12.7%
408,890
+0.1%
0.01%0.0%
Q4 2021$7,799,000
-16.1%
408,533
+8.3%
0.01%
-16.7%
Q3 2021$9,301,000
-5.2%
377,154
+0.0%
0.01%
-14.3%
Q2 2021$9,812,000
-16.1%
377,089
+2.0%
0.01%
-22.2%
Q1 2021$11,699,000
-27.0%
369,529
+7.0%
0.01%
-25.0%
Q4 2020$16,026,000
+282.2%
345,388
+171.1%
0.01%
+200.0%
Q3 2020$4,193,000
-3.7%
127,384
-19.7%
0.00%0.0%
Q2 2020$4,354,000
-53.8%
158,616
-49.6%
0.00%
-63.6%
Q1 2020$9,428,000
+14.3%
314,956
+5.7%
0.01%
+37.5%
Q4 2019$8,250,000
+133.0%
298,044
+53.2%
0.01%
+100.0%
Q3 2019$3,541,000194,5440.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders